Neurology Central

Gut microbiome modulation: potential mechanism uncovered for the treatment of multiple sclerosis


Researchers from Brigham and Women’s Hospital (MA, USA) have discovered that levels of a specific miRNA increase during peak disease in a mouse model of multiple sclerosis (MS) and in untreated MS patients. The study, published in Cell Host & Microbe, indicated that when a synthetic version of the miRNA was orally administered to the mice, it prevented disease. 

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.